Compass Pathways’ Psilocybin Treatment ‘Well-Tolerated’ in Phase II PTSD Trial
Compass Pathways’ Psilocybin Treatment ‘Well-Tolerated’ in Phase II PTSD Trial 12/20/2023

Compass Pathways’ Psilocybin Treatment ‘Well-Tolerated’ in Phase II PTSD Trial 12/20/2023